Pharmabiz

Messe Muenchen India acquires PharmaTech Expo from PharmaTechnologyindex.com

Messe Muenchen India, a subsidiary of Messe München GmbH and a leading organiser of B2B trade fairs in India, has acquired PharmaTech Expo from PharmaTechnologyindex.com Pvt Ltd. (A Division of KNS ...
Pharmabiz

Merck & Moderna to present positive results from phase 3 INTerpath-001 trial for intismeran autogene plus Keytruda at ESMO 2026 Presidential Symposium

Merck & Moderna to present positive results from phase 3 INTerpath-001 trial for intismeran autogene plus Keytruda at ESMO 2026 Presidential Symposium: Rahway, New Jersey Saturday ...
Pharmabiz

Supriya Lifescience joint MD Shivani Wagh featured on Avendus Wealth–Hurun India U35 List 2026

Supriya Lifescience joint MD Shivani Wagh featured on Avendus Wealth–Hurun India U35 List 2026: Our Bureau, Mumbai Saturday, October 24, 2026, 11:30 Hrs [IST] Supriya Lifescienc ...
Pharmabiz

Boehringer Ingelheim and Microsoft partner to drive patient-centric and AI-backed clinical development

Boehringer Ingelheim and Microsoft partner to drive patient-centric and AI-backed clinical development: Cologne, Germany Saturday, October 24, 2026, 12:00 Hrs [IST] Boehringer Ing ...
Pharmabiz

Lupin appoints Brian Savage as president, chief legal officer

Lupin appoints Brian Savage as president, chief legal officer: Our Bureau, Mumbai Saturday, October 24, 2026, 11:15 Hrs [IST] Global pharma major Lupin Limited announced the appoi ...
Pharmabiz

Nivam Orthopaedics partners with Surya Hospitals to establish specialised orthopaedic centres in Mumbai

Nivam Orthopaedics partners with Surya Hospitals to establish specialised orthopaedic centres in Mumbai: Our Bureau, Mumbai ...
Pharmabiz

Medtronic announces positive real-world registry results for Affera Mapping and Ablation System with the Sphere-9 Catheter and the PFA System

Medtronic announces positive real-world registry results for Affera Mapping and Ablation System with the Sphere-9 Catheter and the PFA System: Galway, Ireland Saturday, October 24 ...
Pharmabiz

Gilead to acquire investigational oral IL-23R inhibitor HCXT-2001 from PepStar Therapeutics for $1.275 billion

The transaction provides Gilead with worldwide rights to the IL-23R inhibitor programme, including HCXT-2001, and further strengthens Gilead’s growing inflammation and immunology portfolio, where the ...
Pharmabiz

Prognica Labs and Pinnacology enter co-development and commercialization partnership to advance novel intranasal anxiety therapy

Prognica Labs and Pinnacology enter co-development and commercialization partnership to advance novel intranasal anxiety therapy: Dubai, UAE Saturday, October 24, 2026, 09:00 Hrs ...
Pharmabiz

Corporate oncology care faces margin squeeze as NPPA brings direct hospital supplies under 30% TMR net

Corporate oncology care faces margin squeeze as NPPA brings direct hospital supplies under 30% TMR net: Peethaambaran Kunnathoor, Chennai Saturday, October 24, 2026, 08:00 Hrs [IS ...
Pharmabiz

SEC rejects Fresenius Kabi's request for waiver of Phase III & IV trial for SmofKabiven extra Nitrogen

SEC rejects Fresenius Kabi's request for waiver of Phase III & IV trial for SmofKabiven extra Nitrogen: Our Bureau, New Delhi Saturday, October 24, 2026, 08:00 Hrs [IST] The Subje ...
Pharmabiz

Indian healthcare sees med-tech innovation as a key driver of transformation with nationwide reach

Indian healthcare sees med-tech innovation as a key driver of transformation with nationwide reach: Nandita Vijayasimha, Bengaluru Saturday, October 24, 2026, 08:00 Hrs [IST] Indi ...